Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the national healthcare safety Network, 2015–2017. Infect Control Hosp Epidemiol. 2020;41:1–18.
Yoon YK, Lee SE, Lee J, Kim HJ, Kim JY, Park DW, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother. 2011;66:1831–8.
Article CAS PubMed Google Scholar
Kara A, Devrim I, Bayram N, Katipoglu N, Kıran E, Oruc Y, et al. Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Braz J Infect Dis. 2015;19:58–61.
Ford CD, Lopansri BK, Haydoura S, Snow G, Dascomb KK, Asch J, et al. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infect Control Hosp Epidemiol. 2015;36:47–53.
Gedik H, Yildırmak T, Simsek F, Kanturk A, Arica D, Aydin D, et al. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies. J Infec in Dev Ctries. 2014;8:1113–8.
Alevizakos M, Gaitanidis A, Nasioudis D, Tori K, Flokas ME, Mylonakis E. Colonization with vancomycin-resistant enterococci and risk for bloodstream infection among patients with malignancy: a systematic review and meta-analysis. Open Forum Infect Dis. 2016;4:246.
Mazuski JE. Vancomycin-resistant Enterococcus: risk factors, surveillance, infections, and treatment. Surg Infect. 2008;9:567–71.
Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS ONE. 2013;8: e75658.
Article CAS PubMed Central PubMed Google Scholar
Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS ONE. 2012;7: e47297.
Article CAS PubMed Central PubMed Google Scholar
Metallidis S, Chatzidimitriou M, Tsona A, Bisiklis A, Lazaraki G, Koumentaki E, et al. Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece. Braz J Infect Dis. 2006;10:179–84.
Suntharam N, Lankford MG, Trick WE, Peterson LR, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis. 2002;43:183–8.
Mioljevic V, Markovic-Denic L, Vidovic A, Jovanovic M, Tosic T, Tomin D. Risk factors for vancomycin-resistant Enterococcus colonization in hematologic patients. Vojnosanit Pregl. 2013;70:1109–16.
Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect. 2012;18:388–94.
Article CAS PubMed Google Scholar
Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer. 2011;19:231–7.
Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant Enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transpl. 2007;13:615–21.
Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR. Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol. 1999;20:660–3.
Article CAS PubMed Google Scholar
da Batistao DW, Gontijo-Filho F, Conceicao PP, Oliveira N, de Ribas AG. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012;107:57–63.
Reid KC, Cockerill FR, Patel R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis. 2001;32:1540–6.
Article CAS PubMed Google Scholar
Narciso-Schiavon JL, Borgonovo A, Marques PC, Tonon D, Bansho ETO, Maggi DC, et al. Enterococcus casseliflavus and Enterococcus gallinarum as causative agents of spontaneous bacterial peritonitis. Ann Hepatol. 2015;14:270–2.
Article CAS PubMed Google Scholar
Vasilakopoulou A, Vourli S, Siafakas N, Kavatha D, Tziolos N, Pournaras S. Enterococcus casseliflavus bacteraemia in a patient with chronic renal disease. Infect Dis Rep. 2020;12:70–3.
Article PubMed Central PubMed Google Scholar
Amaro P, Ferreira J, Viegas R, Cardoso A, Correia J, Maurício H. Multifocal joint infection caused by Enterococcus gallinarum. Mod Rheumat Case Reports. 2021;5:384–6.
Nomura T, Hashimoto Y, Kurushima J, Hirakawa H, Tanimoto K, Zheng B, et al. New colony multiplex PCR assays for the detection and discrimination of vancomycin-resistant enterococcal species. J Microbiol Methods. 2018;145:69–72.
Article CAS PubMed Google Scholar
Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165–93.
Shay DK, Goldmann DA, Jarvis WR. Reducing the spread of antimicrobial-resistant microorganisms: control of vancomycin-resistant enterococci. Pediatr Clin North Am. 1995;42:703–16.
Article CAS PubMed Google Scholar
Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, et al. SHEA/APIC Guideline: Infection prevention and control in the long-term care facility. Am J Infect Control. 2008;36:504–35.
Article PubMed Central PubMed Google Scholar
Tresoldi AT, Cardoso LGO, Castilho GV, Dantas SRPE, von Nowakonski A, Pereira RM, et al. Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a Brazilian teaching hospital. Braz J Infect Dis. 2006;10:239–41.
Maschieto A, Martinez R, Palazzo ICV, da Darini AL. Antimicrobial resistance of Enterococcus sp. isolated from the intestinal tract of patients from a university hospital in Brazil. Mem Inst Oswaldo Cruz. 2004;99:763–7.
Akturk H, Sutcu M, Somer A, Karaman S, Acar M, Unuvar A, et al. Results of four-year rectal vancomycin-resistant enterococci surveillance in a pediatric hematology-oncology ward: From colonization to infection. Tjh. 2016;33:244–7.
Suzuki H, Hase R, Otsuka Y, Hosokawa N. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan. J Infect Chemother. 2017;23:390–3.
Corso A, Faccone D, Gagetti P, Togneri A, Lopardo H, Melano R, et al. First report of VanA Enterococcus gallinarum dissemination within an intensive care unit in Argentina. Int J Antimicrob Agents. 2005;25:51–6.
Article CAS PubMed Google Scholar
Eshaghi A, Shahinas D, Li A, Kariyawasam R, Banh P, Desjardins M, et al. Characterization of an Enterococcus gallinarum isolate carrying a dual vanA and vanB cassette. J Clin Microbiol. 2015;53:2225–9.
Article CAS PubMed Central PubMed Google Scholar
Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS ONE. 2012;7: e47297.
Article CAS PubMed Central PubMed Google Scholar
Worth LJ. Vancomycin-resistant enterococci in patients with hematological malignancy: curbing an endemic pathogen. Leuk Lymphoma. 2014;55:1225–6.
Papadimitriou-Olivgeris M, Drougka E, Fligou F, Kolonitsiou F, Liakopoulos A, Dodou V, et al. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection. 2014;42:1013–22.
留言 (0)